Orion Oyj ORINY · OTC
$46.65 +1.63% (+$0.75)
Summary
66 / 100 · Bulios Score
What speaks for it
- Out of every 100 EUR of revenue, 29 EUR is left as net profit.
- It earns 41 EUR a year on every 100 EUR of invested capital.
- Revenue grew by 12% a year over the last 3 years.
What to watch
- The share price is above the Bulios Fair Price.
- Earnings per share fell by 12% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensivePrice against the Bulios Fair Price
P/E against the industry (Drug Manufacturers - General)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 40.0 EUR for 1 EUR of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 12% a year over 5 years. Over the last 3 years it grew by 12% a year. Earnings per share fell by 12% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 EUR of revenue goes
- Cost of sales 34 EUR
- Research and development 11 EUR
- Sales and administration 19 EUR
- Taxes and other 7.4 EUR
- Net profit 29 EUR
Net profit, industry median (Drug Manufacturers - General) 10 EUR
Out of every 100 EUR of revenue, 29 EUR is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, stretched- Yield
- 2.13%
- Paid out of profit
- 85%
You receive $0.99 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 2
- Hold 1
- Sell 0
No analyst has published a price target.
67% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.